Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Medical / Pharmaceuticals

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 4

FDA clears first neonatal magnetic resonance imaging device
FDA clears first neonatal magnetic resonance imaging device
7/20/2017 2:11:01 PM
Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).
Spare the surgery: Drugs may combat hydrocephalus, Yale study finds
Spare the surgery: Drugs may combat hydrocephalus, Yale study finds
7/20/2017 6:02:51 AM
Clinically available drugs may help combat a potentially lethal form of hydrocephalus now treated mainly by brain surgery, a new Yale-led study has found.
“Regenerative Medicine,” An Amazon Best-Selling Book is Free For One More Day (07/21/2017)
“Regenerative Medicine,” An Amazon Best-Selling Book is Free For One More Day (07/21/2017)
7/20/2017 6:00:00 AM
Best Seller Publishing announces the release of Darla Logan’s new book, “Regenerative Medicine: Proven Ways to Eliminate Pain, Restore Mobility, and Repair Athletic Injuries.” It will be available for free download in the Amazon Kindle Store for one more day on July 21st.  Every day there are thousands of people suffering from pain.
Failures in stethoscope hygiene can lead to patient infections
Failures in stethoscope hygiene can lead to patient infections
7/20/2017 5:42:33 AM
That’s the question raised by a new quality improvement project published in the July issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology ( APIC ).
Samsung’s ‘Crystal Vue™’ Ultrasound Imaging Technology Features on the Cover of the American Journal of Obstetrics & Gynecology
Samsung’s ‘Crystal Vue™’ Ultrasound Imaging Technology Features on the Cover of the American Journal of Obstetrics & Gynecology
7/20/2017 5:28:49 AM
Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, today announced that its diagnostic imaging technology for women’s health ‘Crystal Vue™’ is featured on the cover of the American Journal of Obstetrics & Gynecology (AJOG) in the July edition.
Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole), A Novel Treatment For Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients
Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole), A Novel Treatment For Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients
7/20/2017 4:54:17 AM
Pfizer Inc. (NYSE:PFE) and Basilea Pharmaceutica Ltd. (SIX:BSLN), an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, today announced they have completed the licensing agreement whereby Pfizer has obtained the exclusive commercialization rights in Europe to CRESEMBA (isavuconazole), a novel …
GSK updates on UK manufacturing network
GSK updates on UK manufacturing network
7/19/2017 3:49:35 PM
GSK today set out several announcements made by the company to improve the efficiency and competitiveness of its manufacturing network. These include both investments for respiratory and HIV medicines manufacturing in the UK and strategic reviews, including the sale of several products and a proposal to close a UK manufacturing site.
GE Healthcare Premieres Heroines of Health, A Documentary Highlighting the Courageous Women Who Tackle Some of the Toughest Challenges in Global Health
GE Healthcare Premieres Heroines of Health, A Documentary Highlighting the Courageous Women Who Tackle Some of the Toughest Challenges in Global Health
7/19/2017 1:44:00 PM
GE Healthcare announced the world premiere of  Heroines of Health, a documentary by Emmy-award winning filmmaker Lisa Russell, MPH.  The film follows three heroines, from India, Kenya and Indonesia, who are overcoming steep challenges and expectations to bring better health and hope to their communities.  Women comprise 75 percent of the global healthcare workforce, yet …
Study: Reducing hospital readmissions does not increase mortality rates
Study: Reducing hospital readmissions does not increase mortality rates
7/19/2017 12:39:59 PM
Recent advances in reducing hospital readmission rates for three key medical conditions occurred without causing an increase in death rates, according to a new Yale study.
FDA approves Vosevi for Hepatitis C
FDA approves Vosevi for Hepatitis C
7/19/2017 8:21:18 AM
The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.
FDA approves new treatment to reduce the risk of breast cancer returning
FDA approves new treatment to reduce the risk of breast cancer returning
7/18/2017 12:04:05 PM
The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.
Philips to strengthen its ultrasound business with the acquisition of clinical applications and imaging software company TOMTEC
Philips to strengthen its ultrasound business with the acquisition of clinical applications and imaging software company TOMTEC
7/18/2017 10:00:53 AM
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has signed an agreement to acquire TomTec Imaging Systems GmbH (TOMTEC), a leading provider of intelligent image analysis software, especially for diagnostic ultrasound.
Johnson & Johnson Reports 2017 Second-Quarter Results
Johnson & Johnson Reports 2017 Second-Quarter Results
7/18/2017 9:59:53 AM
Johnson & Johnson (NYSE: JNJ) today announced sales of $18.8 billion for the second quarter of 2017, an increase of 1.9% as compared to the second quarter of 2016.
New PTSD study identifies potential path to treatment
New PTSD study identifies potential path to treatment
7/18/2017 9:35:16 AM
A study of post-traumatic stress disorder (PTSD) — conducted by the VA National Center for PTSD (NCPTSD), National PTSD Brain Bank, and Yale University — has identified a new potential mechanism contributing to the biology of the disorder that may be targeted by future treatments.
HIMSS Asia Pacific and Elsevier Launch the CMO of the Year Award
HIMSS Asia Pacific and Elsevier Launch the CMO of the Year Award
7/18/2017 9:25:45 AM
HIMSS Asia Pacific, a cause-based, not-for-profit organization focused on better health through information technology (IT), and Elsevier, the information analytics company specializing in science and health, are proud to launch the Chief Medical Officer (CMO) of the Year Award as part of the Asia Pacific HIMSS-Elsevier Digital Healthcare Award 2017.
Roche’s OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia
Roche’s OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia
7/17/2017 4:00:45 PM
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that OCREVUS® (ocrelizumab) has been approved by the Australian Therapeutic Goods Administration (TGA) for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS), marking the second approval of OCREVUS for both indications following the FDA decision in the US in March …
Bayer and White Ribbon Alliance Partnership Reaches 1,200 Women in 91 Communities through Every Woman Every Child Self-Care Programs
Bayer and White Ribbon Alliance Partnership Reaches 1,200 Women in 91 Communities through Every Woman Every Child Self-Care Programs
7/17/2017 3:53:26 PM
Bayer and the White Ribbon Alliance (WRA) announce that two-years into their partnership and less than one year from community project launch, their  Every Woman Every Child  commitment to empower women to practice self-care has reached 1,200 women in 91 communities across four developing countries.
Novartis confirms 5 year data for first and only fully-human IL-17A inhibitor Cosentyx® reinforcing sustained efficacy and safety profile in psoriasis
Novartis confirms 5 year data for first and only fully-human IL-17A inhibitor Cosentyx® reinforcing sustained efficacy and safety profile in psoriasis
7/17/2017 3:38:22 PM
Novartis, a global leader in Immunology & Dermatology, confirmed today positive 5 year efficacy and safety results for Cosentyx® from a Phase III long-term extension study in patients with moderate-to-severe plaque psoriasis[1].
Statement from FDA Commissioner Scott Gottlieb, M.D., on National Academies of Sciences, Engineering, and Medicine report on pain management and prescription opioid abuse
Statement from FDA Commissioner Scott Gottlieb, M.D., on National Academies of Sciences, Engineering, and Medicine report on pain management and prescription opioid abuse
7/17/2017 2:40:13 PM
In March 2016, the FDA asked the National Academies of Sciences, Engineering, and Medicine (NASEM) to outline the state of the science regarding prescription opioid abuse and misuse, as well as the evolving role that opioids play in pain management.
Teens may be missing vaccines because parents aren’t aware they need one
Teens may be missing vaccines because parents aren’t aware they need one
7/17/2017 12:21:16 PM
Parents may be up to speed on what vaccines their children need for kindergarten, but may be less sure during high school years, a new national poll suggests.